Over expression of vascular endothelial growth factor and its receptor during the development of estrogen-induced rat pituitary tumors may mediate estrogen-initiated tumor angiogenesis

Carcinogenesis

Volumn 18, Issue 6, 1997, Pages 1155-1161

  Banerjee, Sushanta K ^a,b,d   Sarkar, Dipak K ^c   Weston, Allan P ^a,b   De, Alok ^c   Campbell, Donald R ^a,b  

^a VA Medical Center   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c WASHINGTON STATE UNIVERSITY   (United States)

^d Molec Gastroenterol Pancreatic C   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VON WILLEBRAND FACTOR;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING SITE; BLOOD VESSEL; CARCINOGENESIS; CELL POPULATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE OVEREXPRESSION; HYPOPHYSIS TUMOR; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RAT; TUMOR VASCULARIZATION;

ANIMALS; BLOTTING, WESTERN; ENDOTHELIAL GROWTH FACTORS; ESTRADIOL; FEMALE; IMMUNOHISTOCHEMISTRY; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; PITUITARY GLAND, ANTERIOR; PITUITARY NEOPLASMS; RATS; RATS, INBRED F344; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, GROWTH FACTOR; RECEPTORS, VASCULAR ENDOTHELIAL GROWTH FACTOR; SENSITIVITY AND SPECIFICITY; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS; VON WILLEBRAND FACTOR;

EID: 0031408416     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/18.6.1155     Document Type: Article

References (42)

1. Henderson, B.E., Ross, R. and Bernstein, L. (1988) Estrogen as a cause of human cancer. Cancer Res., 48, 246-253.
2. Barrett, J.C. (1992) Molecular mechanisms of hormonal carcinogenesis. In Li, J.J., Nandi, S. and Li, S.A. (eds) Hormonal Carcinogenesis. Springer-Verlag. New York, vol. 1, pp. 159-163.
3. Furth, J. and Clifton, K.H. (1966) Experimental pituitary tumors. In Harris, G.W. and Donovan, B.T. (eds) The Pituitary Gland. Butterworths, London, pp. 460-497.
4. Elias, K.A. and Weiner, R.I. (1984) Direct arterial vascularization of estrogen-induced prolactin-secreting anterior pituitary tumors. Proc. Natl Acad. Sci. USA, 81, 4549-4553.
5. Elias, K.A. and Weiner, R.I. (1987) Inhibition of estrogen-induced anterior pituitary enlargement and arteriogenesis by bromocriptine in Fisher 344 rats. Endocrinology, 120, 617-621.
6. Takechi, A., Uozumi, T., Kawamoto, K., Ito, A., Kurisu, K. and Sudo, K. (1994) Inhibitory effect of TNP-470, a new anti-angiogenic agent, on the estrogen induced pituitary tumors. Anticancer Res., 14, 157-162.
7. Cockerill, G.W., Gamble, J.R. and Vadas, M.A. (1995) Angiogenesis: model and modulators. Int. Rev. Cytol., 159, 113-159.
8. Klagsburn, M. and D'Amore, P.A. (1991) Regulators of angiogenesis. Ann. Rev. Physiol., 53, 217-239.
9. Berkman, R.A., Merrill, M.J., Reinhold, W.C., Monacci, W.T., Saxena, A., Clark, W.C., Robertson, J.T., Ali, I.U. and Oldfield, E.H. (1993) Expression of vascular permeability factor/vascular endothelial growth factor gene central nervous system neoplasms. J. Clin. Invest., 91, 153-159.
10. Zagzag, D. (1995) Angiogeneic growth factors in neural embryogenesis and neoplasia Am. J. Pathol., 146, 293-309.
11. Takano, S., Yoshii, Y., Kondo, S., Suzuki, H., Maruno, T., Shirai, S. and Nose, T. (1996) Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res., 56, 2185-2190.
12. Takahashi, Y., Kitadai, Y., Bucana, C.D., Cleary, K.R. and Ellis, L.M. (1995) Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer. Cancer Res., 55, 3964-3968.
13. Brown, L.F., Berse, B., Jackman, R.W., Tognazzi, K., Manseau, E.J., Senger, D.R. and Dvorak, H.F. (1993) Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 53, 4727-4735.
14. Olson, T.A., Mohanraj, D., Carson, L.F. and Ramkrishnan, S. (1994) Vascular permeability factor gene expression in normal and neoplastic human ovaries. Cancer Res., 54, 276-280.
15. Yoshiji, H., Gomez, D.E., Shibuya, M. and Thorgeirsson, U.P. (1996) Expression of vascular endothelial growth factor, its receptor, and other angiogenic factors in human breast cancer. Cancer Res., 56, 2013-2016.
16. Kim, K.J., Li, B., Winer, J., Armanini, M., Gillett, N., Phillips, H.S. and Ferrara, N. (1993) Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumor growth in vivo. Nature (Lond.), 362, 841-844.
17. 121. Cancer Res., 55, 5296-5301.
18. Saleh, M., Stacker, S.A. and Wilks, A.F. (1996) Inhibition of growth of C6 glioma cells in vivo by expression of antisense vascular endothelial growth factor sequence. Cancer Res., 56, 393-401.
19. Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, S., Powell-Braxton, L., Hillan, K.J. and Moore, M.W. (1996) Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature, 380, 439-342.
20. Ferrara, N., Winer, J., Burton, T., Rowland, A., Siegel, M., Phillips, H.S., Terrell, T., Keller, G.A. and Levinson, A.D. (1993) Expression of vascular endothelial growth factor does not promote transformation but confers a growth advantage in vivo to chinese hamster ovary cells. J. Clin. Invest., 91, 160-170.
21. Shibuya, M., Yamaguchi, S., Yamane, A., Ikeda, T., Tojo, A., Matsushime, H. and Sato, M. (1990) Nucleotide sequence and expression of a novel human receptor type tyrosine kinase (flt) closely related to the fms family. Oncogene, 5, 519-524.
22. de Vries, C., Escobedo, J.A., Ueno, H., Houck Ferrara, N. and Williams, L.T. (1992) The fms-like tyrosine kinase, a receptor for cellular endothelial growth factor. Science, 255, 989-991.
23. Terman, B.I., Dougher-Vermazen, M., Carrion, M.E., Dimitrov, D., Armellino, D.C., Gospodarowicz, D. and Bohlen, P. (1992) Identification of KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem. Biophys. Res. Commun., 187, 1579-1586.
24. Mathews, W., Jordan, C.T., Gavin, M., Jenkins, N.A., Copeland, N.G. and Lemischka, I.R. (1991) A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc. Natl Acad. Sci. USA, 88, 9026-9030.
25. Quinn, T.P., Peters, K.G., DeVries, C. Ferrara, N. and Williams, L.T. (1993) Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium. Proc. Natl Acad. Sci. USA, 90, 7533-7537.
26. Millauer, B., Wizigmann-Voos, S., Martinez, R., Moller, N.P.H., Risau, W. and Ullrich, A. (1993) High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell, 72, 835-846.
27. Peters, K.G., De-Vries, C. and Williams, L.T. (1993) Vascular endothelial growth factor receptor expression during embryogenesis and tissue repair suggests a role in endothelial differentiation and blood vessel growth. Proc. Natl Acad. Sci. USA, 90, 8915-8919.
28. Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. and Heldin, C.-H. (1994) Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem., 269, 26988-26995.
29. Millauer, B., Shawver, L., Plate, K., Risau, W. and Ullrich, A. (1994) Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant. Nature (Lond.), 367, 576-579.
30. Kolch, W., Martiny-Baron, G., Kieser, A. and Marme, D. (1995) Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis. Breast Cancer Res. Treat., 36, 139-155.
31. Cullinan Bove, K. and Koos, R.D. (1993) Vascular endothelial growth factor/ vascular permeability factor expression in rat uterus: rapid stimulation by estrogen correlates with estrogen-induced increases in uterine capillary permeability and growth. Endocrinology, 133, 829-837.
32. Burns, G. and Sarkar, D.K. (1993) Transforming growth factor-beta-1-like immunoreactivity in the pituitary gland on the rat: effect of estrogen. Endocrinology, 133, 1444-1449.
33. Berm, S., Cotran, S.S. and Folkman, J. (1972) Tumor angiogenesis: a quantitative method for histological grading. J. Natl Cancer Inst., 48, 347-356.
34. Bosari, S., Lee, A.K., DeLellis, R.A., Wiley, B.D., Heatley, G.J. and Silverman, M.L. (1992) Microvessel quantitation and prognosis in invasive breast carcinoma. Hum. Pathol., 23, 755-761.
35. Petrovic, L.M., Burroughs, A. and Scheuer, P.J. (1989) Hepatic sinusoidal endothelium: Ulex lectin binding. Histopathology, 14, 233-243.
36. Williams, R.J., Robertson, D. and Davies, A.J. (1989) Identification of vascular endothelial cells in murine omentum using lectin. Dolichos biflorus agglutinin: possible applications in the study of angiogenesis. Histochem. J., 21, 271-278.
37. Risau, W. (1995) Differentiation of endothelium FASEB J., 9, 926-933.
38. Samoto, K., Ikezaki, K., Yokoyama, N. and Fukui, M. (1994) P-glycoprotein expression in brain capillary endothelial cells after focal ischaemia in rat. Neurol. Res., 16, 217-223.
39. Sharkey, A.M., Charnock-Jones, D.S., Boocock, C.A., Brown, K.D. and Smith, S.K. (1993) Expression of mRNA for vascular endothelial growth factor in human placenta. Reprod. Fertil., 99, 609-615.
40. Charnock-Jones, D.S., Sharkey, A.M., Rajput-Williams, J., Burch, D., Schofield, J.P., Fountain, S.A., Boocock, C.A. and Smith, S.K. (1993) Identification and localization of alternately spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol. Reprod., 48, 1120-1128.
41. Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-364.
42. Liotta, L.A., Steeg, P.S. and Stetler-Stevenson, W.G. (1991) Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell, 64, 327-336.